Life Sciences
BlueRock Therapeutics will utilize Rune Labs' StriveStudy clinical trial platform and FDA-cleared Apple Watch data-collection tool to monitor Parkinson's disease.
Also, EpiSoft announces the integration of its cancer management platform with My Health Record.
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
DenovAI will create an AI-powered platform to discover potential antibodies from scratch, then suggest which ones can be used as effective drugs.
Lucira's diagnostic is the first over-the-counter at-home combination test for COVID-19 and flu authorized by the FDA.
The Copenhagen-based digital health company will work with Novartis to build digital health tools for chronic conditions where they see unmet needs and the potential for disease progression.
Diathrive Health users will have access to Mark Cuban Cost Plus Drug Company's lower-cost diabetes medication and testing supplies.
The funds will be used to expand its research and development teams in the U.S. and Israel.
The Digital Medicine Society partnered with digital health and pharma players like the FDA, Janssen, GSK, Medable and THREAD to build a toolkit aimed at improving diversity in digital research.
Marker Learning, which provides virtual assessments for learning disabilities, raised $15 million, and reproductive care company Twentyeight Health scored $8.3 million.